Table 1. Patient characteristics (original cohort).
| Characteristics | Total | RLNA* | Non-RLNA† | p-value | |
|---|---|---|---|---|---|
| Total | 335 | 170 | 165 | ||
| Age (yr) | <0.001 | ||||
| ≤55 | 150 | 88 (52) | 62 (38) | ||
| >55 | 185 | 82 (48) | 103 (62) | ||
| Mean (SD) | 55.0 (10) | 59.6 (12) | |||
| FIGO stage | 0.005 | ||||
| IIB | 14 | 5 (3) | 9 (6) | ||
| IIC | 53 | 28 (17) | 25 (15) | ||
| IIIA | 16 | 8 (5) | 8 (5) | ||
| IIIB | 52 | 16 (9) | 36 (22) | ||
| IIIC | 165 | 99 (58) | 66 (40) | ||
| IV | 35 | 14 (8) | 21 (13) | ||
| Uterine preservation | 24 | 3 (2) | 21 (13) | <0.001 | |
| Residual tumor | <0.001 | ||||
| None | 266 | 152 (89) | 114 (69) | ||
| <1 cm | 69 | 18 (11) | 51 (31) | ||
| Chemotherapy | 0.235 | ||||
| Non-TP | 72 | 41 (24) | 31 (19) | ||
| TP | 263 | 129 (76) | 134 (81) | ||
| Treatment era | 0.003 | ||||
| <2010 | 206 | 118 (69) | 88 (53) | ||
| ≥2010 | 129 | 52 (31) | 77 (47) | ||
Values are presented as number (%).
FIGO, International Federation of Gynecology and Obstetrics; RLNA, retroperitoneal lymphadenectomy; SD, standard deviation; TP, taxane plus platinum.
*The RLNA group included patients who underwent full-staging standard surgery with RLNA.
†The non-RLNA group included patients who underwent non-staging limited surgery without RLNA.